# Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10

> **NCT02333305** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 19 (actual)

## Conditions studied

- Ataxia-oculomotor Apraxia 1

## Interventions

- **DIETARY_SUPPLEMENT:** CoQ10
- **OTHER:** Sanomit Placebo

## Key facts

- **NCT ID:** NCT02333305
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2017-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02333305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02333305, "Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02333305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*